Tag Archives: Gene Patents

Tomorrow Morning on NPR: BIO, ACLU Discuss Gene Patenting

You can listen from your desk at http://www.wbur.org/listen. Callers will have the opportunity to ask questions after the first 20 minutes. If you’re interested in the topic, you can find background material on gene patenting at http://bio.org/ip/genepat/ and our amicus brief in the ACLU lawsuit is posted at http://bio.org/ip/amicus/documents/BIOAmicusBriefACLU-Myriad12-09.pdf.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Department of State: Foster Climate Change Solutions, Biodiversity, & Economic Development with IPR Protections

CropLife has recently published their newest video interview last week with Carrie LaCrosse, of the Office of Intellectual Property Enforcement at the U.S. Department of State. LaCrosse discusses the value of IP for agriculture, looking in particular at new plant varieties and how IP is part of the solution in addressing the issues of food security.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO to USA Today: Patents Promote Innovation

Public debate over access to, and use of, genetic technology is a good thing. It requires the consideration of many factors, including coverage and cost, concerns over genetic discrimination and myriad regulatory issues.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Patent Docs: Falsehoods, Distortions and Outright Lies in the Gene Patenting Debate

Patent Docs blog reviewed the most repeated criticisms of the patenting of genetic materials, providing a critical hand to assist non-technical observers of the debate currently swirling around in legal, scientific, and academic circles.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Patenting Genes: NPR Talks IP with BIO

Today, June 4, 2009 at 1:00 PM ET DC’s WAMU Radio Station (88.5 FM) or at  http://wamu.org/programs/kn/09/06/04.php#26424 The genetic material in our cells make us who we are. But since 1982, the U.S. Patent Office has issued tens of thousands of patents to private companies for gene-related products. The biotechnology industry says these patents are necessary to spur innovation. Opponents say they actually stifle science. We examine the intersection of cutting-edge genetic research and intellectual Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: